How to buy Anthropic stock: the ANT ticker, what's known about the IPO date, how brokers handle IPO shares, and what pre-IPO offers really are

How to buy Anthropic stock is a question with a short answer for now: you can't, at least not on a stock exchange. Anthropic filed its S-1 registration statement publicly on October 26, 2026. It says Anthropic plans to sell Class A common stock on the Nasdaq Global Select Market under the symbol ANT, but it doesn't set a date, a price range or the number of shares. Until the offering prices and trading starts, the only routes are a broker's IPO allocation, which isn't guaranteed, or private "pre-IPO" deals that regulators warn about. Our breakdown of the S-1's numbers covers what the filing says about the business; this explainer covers the buying part.

This explainer is based on Anthropic's S-1 on SEC EDGAR, the IPO pages of Fidelity, Charles Schwab and Robinhood, SEC and FINRA investor-education material and rules, and reporting on the filing by The Next Web and Yahoo Finance, checked October 27, 2026. It describes facts and processes only. It isn't investment advice.

The short version

• Ticker: ANT, for Class A shares on the Nasdaq Global Select Market, according to the S-1.
• Date and price: not set. The S-1's price range reads "between $ and $." The Wall Street Journal reported a target of the week of November 16, according to The Next Web; Anthropic hasn't announced a date. Under the SEC's 15-day rule, a roadshow can't start before about November 10, by 9to5AI's arithmetic.
• Banks: Goldman Sachs and Morgan Stanley lead 22 underwriters, the S-1's cover shows.
• Before the IPO: you can request shares through a broker's IPO program if you qualify, but allocations aren't guaranteed, and none of the broker pages reviewed mentions Anthropic.
• After the IPO: once trading starts, anyone with a brokerage account that offers Nasdaq stocks can buy at the market price, which can differ sharply from the offering price.
• Pre-IPO offers: usually fund interests, not shares. The SEC and FINRA both warn about pre-IPO scams.

What is the Anthropic stock symbol?

ANT. The cover of the S-1 says Anthropic has applied to list its Class A common stock on the Nasdaq Global Select Market under that symbol. Before October 26, no ticker had been confirmed, as our earlier IPO explainer noted; symbols such as "ANTH.PVT" on finance sites are placeholders for a private company, not tradable tickers.

Class A is the only class being sold. The other classes, which keep voting control with Anthropic's founders and its Long-Term Benefit Trust, aren't offered to the public. The S-1 warns that the structure "may effectively eliminate the ability of holders of our Class A common stock to influence important decisions," as our trust explainer and the S-1 breakdown describe.

When is the Anthropic IPO, and at what price?

Neither is set. The S-1 says the shares will be sold "as soon as practicable after this registration statement becomes effective." What's been reported:

Last verified: October 27, 2026

The blanks will be filled in later filings. As of October 27, 2026, Anthropic hadn't filed an amended S-1 with a price range, and Nasdaq's IPO calendar, last updated October 26, didn't list the offering. The SEC's investor bulletin on IPOs says the final prospectus "generally includes information related to the final offering price," which usually isn't available when the preliminary prospectus goes out. A valuation figure doesn't tell you the share price; that depends on the share count, which is still blank.

How do IPO shares get allocated?

The company and its underwriters decide, and most shares usually go to institutions. Investor.gov, the SEC's investor-education site, says individuals "may still find it difficult to buy IPO shares," that underwriters and the issuer control the process, and that online brokers "often have only a small allotment of shares to sell to the public." When demand exceeds supply, it says, the excess "can only be satisfied once trading in the IPO shares begins."

FINRA rules shape who can buy. Rule 5130 bars member firms from selling new issues to "restricted persons," such as broker-dealer employees and certain portfolio managers, which is why brokers ask you to confirm you aren't one. Rule 5131 bans using IPO allocations to reward investment-banking business.

Anthropic hasn't announced whether any shares are set aside for individual investors in the US. The S-1's underwriting section doesn't describe a directed share program, and the underwriter table's share counts are blank. Some existing stockholders will sell shares alongside Anthropic, the filing says, without naming them yet.

Can I get Anthropic IPO shares through Fidelity, Schwab or Robinhood?

Possibly, if your broker gets an allocation and you qualify, but none of these brokers' IPO pages mentions Anthropic as of October 27, 2026, and none promises shares in any deal. Here's how each says its program works:

Last verified: October 27, 2026

Allocation methods differ. Fidelity says it ranks customers by assets and the revenue their accounts generate, and that asking for more shares doesn't improve your odds. Robinhood says its "model randomly selects who receives IPO shares from a pool of everyone who submitted a request." Schwab says allocations are limited and not guaranteed.

Two other points from the brokers' pages are worth knowing. Fidelity says IPO shares can't be bought on margin for at least 30 days after pricing. Robinhood says you can request shares only once the underwriters set the initial price range, which hasn't happened for Anthropic.

Can I buy Anthropic stock before the IPO?

Not as an ordinary investor buying shares from the company. What's sold as "pre-IPO Anthropic stock" is usually an interest in a fund or vehicle that says it holds, or will acquire, shares.

FINRA published a warning on this on August 18, 2026, "Know the Risks of Pre-IPO Funds and Potential Fraud." It says such offers often come through "a fund formed to acquire interests in the company," that buyers may be "several layers removed from the actual stock," and that there can be "significant costs associated with acquiring interests." It also says a fund manager "might not have a real plan or ability to acquire the shares they promise," and adds: "You can't be certain the private company will actually complete an IPO." Its practical advice includes being wary of unsolicited offers and to "Never send funds directly to the individual."

The SEC's Office of Investor Education and Advocacy lists similar red flags in its "Pre-IPO Investment Scams" investor alert (June 7, 2024):

• promoters who say an IPO is "imminent" or will happen "this year";
• claims of "no upfront fees" that hide markups;
• cold calls and pressure, including to cash out 401(k) accounts;
• pitches built on emerging technologies such as "artificial intelligence (AI)."

The alert says to "check to see whether the seller is currently registered or licensed" using the free search tool on Investor.gov, and never to base decisions "solely on information from social media platforms or apps." Now that Anthropic's IPO has a filing and reported timing, "imminent" pitches have a real event to point to, which is exactly the pattern the SEC describes.

Can I buy ANT once it starts trading?

Yes, through any brokerage account that offers Nasdaq-listed stocks, at the market price. Investor.gov notes that for popular IPOs, excess demand is met only once trading begins, which is why the opening price can be far from the offering price.

Shares held by insiders are usually locked up for a period after the IPO; the SEC's bulletin gives 180 days as typical. Anthropic's S-1 sets out a staged schedule under a 180-day lock-up, with an extended 365-day lock-up for some holders. Some shares held by non-founder directors, officers and certain current and former employees and consultants can be sold from the first trading day after the prospectus date, with further releases 27, 48, 62 and 76 days after that date and more tied to later earnings releases. The share counts are still blank. When large blocks become sellable, prices can move.

Can I buy Anthropic stock outside the US?

The S-1 says the offering "includes public offerings in Australia, Canada, certain member states of the European Economic Area," Japan, Switzerland and the UK, but that Anthropic doesn't "currently intend to list our Class A common stock on any exchange in such jurisdictions." Trading would be on Nasdaq. Some of those offerings run on separate local documents: the Australian offering will be made under a separate prospectus lodged with the Australian Securities and Investments Commission, and in certain EEA countries Anthropic will offer shares to retail investors under a separate European prospectus. The S-1 doesn't name the local brokers taking part.

What's confirmed, reported and uncertain

• Confirmed (S-1, October 26, 2026): Class A shares; the ticker ANT; the Nasdaq Global Select Market; Goldman Sachs and Morgan Stanley leading 22 banks; the blank price range and share count; public offerings in six other jurisdictions with no listing there.
• Confirmed (brokers, SEC, FINRA): each broker's eligibility rules and flipping policies; general IPO allocation practice; FINRA Rules 5130 and 5131; the SEC and FINRA pre-IPO warnings.
• Confirmed (S-1): the staged lock-up schedule, with share counts blank; no directed share program described.
• Reported: a listing in the week of November 16, a raise of $100 billion or more and a $1.5 trillion to $2 trillion valuation (WSJ, via The Next Web).
• Uncertain: the IPO date, price and size; whether any shares are reserved for individuals; which retail brokers will get ANT allocations.